The Drug-Induced Respiratory Disease Website

X - Pulmonary edema

X.b

Pulmonary edema, noncardiogenic (NCPE)

5

Evidence level

definite

XVI - Hemorrhage - Bleeding - Hematoma(s)

XVI.e

Alveolar hemorrhage (AH), diffuse AH (DAH)

5

Evidence level

definite

XXII - Acute respiratory/cardiorespiratory failure

XXII.b

Acute lung injury - ARDS

5

Evidence level

definite

XXIV - Interstitial lung disease - Pulmonary infiltrates - Pulmonary fibrosis

XXIV.k

Pulmonary infiltrates

1

Evidence level

low

XXIV.ag

Chemical (toxic) pneumonitis

5

Evidence level

definite

XXVIII - Large airway involvement

XXVIII.b

Epiglottitis

1

Evidence level

low

XXVIII.c

Tracheal injury

1

Evidence level

low

XXIX - Small airway involvement

XXIX.l

Bronchiolitis (a clinical-imaging pattern suggestive of)

2

Evidence level

possible

XXIX.m

Obstructive airway dysfunction (see also IVc, XVx)

5

Evidence level

definite

XXIX.n

Reactive airway dysfunction syndrome (RADS)

5

Evidence level

definite

XXX - Imaging features

XXX.k

Imaging: Centrilobular micronodules (can be diffuse)

1

Evidence level

low

XXX.n

Imaging: A 'tree-in-bud' pattern

1

Evidence level

low

XXXIII - Histopathology (for pulmonary pathology see in ‘Pneumotox’ (a free companion App)

XXXIII.j

Path: Pulmonary edema

1

Evidence level

low

XXXVI - Autoimmune syndromes - Systemic reactions or conditions

XXXVI.r

Anti-GBM-related pneumorenal syndrome and DAH (Goodpasture) or flare of

1

Evidence level

low